Is area under the curve the best parameter for carboplatin induced emetic risk stratification?

Carboplatin (CBDCA)-induced emetic risk is currently classified on the basis of CBDCA-area under the curve (CBDCA-AUC). We investigated the utility of three CBDCA dosage parameters for predicting emesis by CBDCA. Patients with thoracic cancer treated with CBDCA were included. The endpoints were comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozone, Sachiko, Ichikawa, Kazuya, Morise, Masahiro, Matsui, Akira, Kinoshita, Fumie, Matsuzawa, Reiko, Koyama, Junji, Tanaka, Ichidai, Hashimoto, Naozumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648517/
https://www.ncbi.nlm.nih.gov/pubmed/34916721
http://dx.doi.org/10.18999/nagjms.83.4.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648517/
https://www.ncbi.nlm.nih.gov/pubmed/34916721
http://dx.doi.org/10.18999/nagjms.83.4.773

Ejemplares similares